For patients with type 2 diabetes and left ventricular hypertrophy, empagliflozin reduced the risk for cardiovascular death vs placebo.
Apnea-hypopnea index during REM sleep is independently associated with diabetic retinopathy in patients with type 2 diabetes.
Suppressing albuminuria should be an important target of therapy, according to investigators.
Poor glycemic control in patients with newly diagnosed type 1 diabetes, but not type 2 diabetes, was associated with an increased risk for low-trauma fracture.
The patient, who had a history of anorexia nervosa-binge purge type, presented to the emergency department with severe abdominal pain, confusion, disorientation, and was experiencing visual hallucinations.
Compared with patients who have onset type 2 diabetes at a usual age, adults with young-onset type 2 diabetes are hospitalized significantly more often in their lifetimes.
Switching from analogue to human insulin is associated with a small increase in hemoglobin A1c (HbA1c) levels.
To investigate the association between this diabetes drug class and IBD risk, the study authors searched various databases for controlled clinical trials and observational studies involving DPP-4 inhibitors where IBD events were reported.
An inverse dose-dependent association exists between cardiorespiratory fitness and type 2 diabetes risk.
Use of the oral hepatoselective glucokinase activator (GKA) TTP399 for type 2 diabetes does not cause hypoglycemia and has no detrimental effect on plasma lipids or liver enzymes.